BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16539978)

  • 1. [Pharmaceutical distribution and retail pharmacy].
    Meneu R
    Gac Sanit; 2006 Mar; 20 Suppl 1():154-9. PubMed ID: 16539978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alternatives to pharmaceutical distribution and reimbursement].
    Meneu R
    Gac Sanit; 2002; 16(2):171-81. PubMed ID: 11958754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specialty pharmacies and other restricted drug distribution systems: financial and safety considerations for patients and health-system pharmacists.
    Kirschenbaum BE
    Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S13-20. PubMed ID: 19966075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liberalization and integration of drug distribution in the EU 28 and Norway.
    Písek J; Pícha K
    Ceska Slov Farm; 2018; 67(1):14-24. PubMed ID: 30157663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incentives and pharmaceutical reimbursement reforms in Spain.
    Puig-Junoy J
    Health Policy; 2004 Feb; 67(2):149-65. PubMed ID: 14720633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-examining 'professionalism' in pharmacy: a South African perspective.
    Williams KF
    Soc Sci Med; 2007 Mar; 64(6):1285-96. PubMed ID: 17161511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping pharmacy deserts and determining accessibility to community pharmacy services for elderly enrolled in a State Pharmaceutical Assistance Program.
    Pednekar P; Peterson A
    PLoS One; 2018; 13(6):e0198173. PubMed ID: 29864159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Entry of new pharmacies in the deregulated Norwegian pharmaceuticals market--consequences for costs and availability.
    Rudholm N
    Health Policy; 2008 Aug; 87(2):258-63. PubMed ID: 18164509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Projection of future pharmacy service fees using the dispensing claims in hospital and clinic outpatient pharmacies: national health insurance database between 2006 and 2012.
    Ha D; Song I; Lee EK; Shin JY
    BMC Health Serv Res; 2018 May; 18(1):327. PubMed ID: 29724220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Reverse Traffic of Drugs Phenomenon: experience in Galicia, Spain].
    Vázquez-Mourelle R; Rodriguez Costa E; Pose Reino JM; Cadórniga Valiño L
    Rev Esp Salud Publica; 2015 Oct; 89(5):431-45. PubMed ID: 26650469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of managed care on the retail distribution of pharmaceuticals.
    Carroll NV
    Manag Care Interface; 1998 Nov; 11(11):105-8, 111-3. PubMed ID: 10187415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lack of safety in medicine supply].
    Apeland SG
    Tidsskr Nor Laegeforen; 2012 May; 132(9):1062. PubMed ID: 22614301
    [No Abstract]   [Full Text] [Related]  

  • 13. Patterns of pharmacy participation in Medicaid: implications for enrollee access.
    Adams EK; Gavin N
    Inquiry; 1996-1997 Winter; 33(4):339-51. PubMed ID: 9031650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independently owned pharmacy closures in rural America.
    Boyle K; Ullrich F; Mueller K
    Rural Policy Brief; 2012 Jul; (2012 4):1-4. PubMed ID: 22830100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independently owned pharmacy closures in rural America, 2003-2010.
    Boyle K; Ullrich F; Mueller K
    Rural Policy Brief; 2011 Jun; (2011 5):1-4. PubMed ID: 21736184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of service in independent community pharmacies: a strategic group analysis.
    Tipton D
    Health Mark Q; 1999; 16(2):65-80. PubMed ID: 10538735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacy benefit managers and their obligations during serious prescription drug shortages.
    Teagarden JR; Epstein RS
    Clin Pharmacol Ther; 2013 Feb; 93(2):143-5. PubMed ID: 23337523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication access through patient assistance programs.
    Chauncey D; Mullins CD; Tran BV; McNally D; McEwan RN
    Am J Health Syst Pharm; 2006 Jul; 63(13):1254-9. PubMed ID: 16790577
    [No Abstract]   [Full Text] [Related]  

  • 19. Managing wholesaler agreements in the fee-for-service era.
    Fein AJ
    Am J Health Syst Pharm; 2007 Jun; 64(11):1153-4. PubMed ID: 17519455
    [No Abstract]   [Full Text] [Related]  

  • 20. [From community pharmacies to big pharmacy chains: private provision of medicines, health system, and financialization of the Brazilian retail pharmacy market].
    Mattos LV; Silva RMD; Silva FDRPD; Luiza VL
    Cad Saude Publica; 2022; 38Suppl 2(Suppl 2):e00085420. PubMed ID: 36043623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.